Analytical Challenges and Emerging Detection Strategies of Synthetic Cannabinoids in Horse Doping Control.
| Journal | Biomedical chromatography: BMC |
| Study Type | Clinical Study |
| Population | Human participants |
This item covers developments relevant to cannabis medicine and clinical practice. Clinicians monitoring evidence in this area should review the source material.
Synthetic cannabinoids (SCs) were originally synthesized to advance the understanding of the endocannabinoid system, facilitate disease research, and support the development of novel therapeutic agents. Compared with tetrahydrocannabinol, these compounds exhibit substantially higher psychoactive potency and enhanced receptor-binding affinity. The rapid and continuous evolution of SC derivatives presents significant challenges for analytical laboratories and increases the risk of misuse. Furthermore, SCs may be exploited to alter performance in both human and animal sports. The scarcity of comprehensive data regarding their toxicity, pharmacokinetics, and potential performance-enhancing mechanisms has made SCs a priority concern in recent years. This concern spans public health, forensic science, animal welfare, and sports integrity. This review examines the historical development, pharmacological properties, chemical characteristics, and physiological effects of SCs. It also presents a
“This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
Why were synthetic cannabinoids originally created?
Synthetic cannabinoids were originally synthesized to advance understanding of the endocannabinoid system, to facilitate disease research and to support the development of novel therapeutic agents. The review examines this historical development along with the compounds’ pharmacological properties, chemical characteristics and physiological effects.
How do synthetic cannabinoids compare with THC?
Compared with tetrahydrocannabinol (THC), synthetic cannabinoids exhibit substantially higher psychoactive potency and enhanced receptor-binding affinity. At the same time, comprehensive data on their toxicity and pharmacokinetics remain scarce, which limits what is known about their safety.
Why are synthetic cannabinoids a concern in human and animal sports?
The review notes that synthetic cannabinoids may be exploited to alter performance in both human and animal sports, while data on any performance-enhancing mechanisms are scarce. This lack of data has made them a priority concern spanning public health, forensic science, animal welfare and sports integrity.
Why are synthetic cannabinoids hard for testing laboratories to keep up with?
New synthetic cannabinoid derivatives evolve rapidly and continuously, which presents significant challenges for analytical laboratories. According to the review, this ongoing evolution of new derivatives also increases the risk that these compounds will be misused.
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
